D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month data on the first three adult OPGx-LCA5 patients to be pr ...

Bulgarian MRO specialist ETG Maintenance has outlined plans to build a new hangar at Burgas Airport on the Black Sea after reaching a deal with the Bulgarian orthodox church to secure land at the site ...

Ethical Vaccine Development & Public Confidence – GeoVax embraces open regulatory processes, rigorous safety standards, and public access to data, ensuring confidence in its vaccines. These principles ...

Arras Minerals Corp. (TSX-V:ARK)(OTCQB:ARRKF) ("Arras" or "Arras Minerals" or "the Company") is pleased to announce the ...

Diablo’s new copper acquisition comes as BHP cheers its own copper operations Galileo Mining sees promising platinum group ...

Max Estates Limited (MEL), has announced its unaudited Q3 & 9M FY25 financial results. * Real Estate Portfolio of 17 Mn. Sq.

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Q4 2024 Earnings Conference Call February 14, 2025 3:00 AM ETCompany ParticipantsMasamichi Terabatake - Group President ...

The vaccine candidate is being evaluated in a ring vaccination trial as part of a comprehensive public health response ...